Albright, A. L. and R. A. Price, et al. (1983). "Brain stem gliomas of children. A clinicopathological study." Cancer52(12): 2313-9.
Balachandran, V. P. and M. Gonen, et al. (2015). "Nomograms in oncology: more than meets the eye." The Lancet. Oncology16(4): e173-80.
Bernier-Chastagner, V. and J. Grill, et al. (2005). "Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study." Cancer104(12): 2792-7.
Bjerke, L. and A. Mackay, et al. (2013). "Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN." Cancer discovery3(5): 512-9.
Chan, K. M. and D. Fang, et al. (2013). "The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression." Genes & development27(9): 985-90.
Chi, A. S. and R. S. Tarapore, et al. (2019). "Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201." Journal of neuro-oncology145(1): 97-105.
de Quintana-Schmidt, C. and M. J. Alvarez-Holzapfel, et al. (2015). "[Isocitrate dehydrogenase type I mutation as a prognostic factor in glioblastoma and a literature review]." Neurocirugia (Asturias, Spain)26(6): 276-83.
Dolecek, T. A. and J. M. Propp, et al. (2012). "CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009." Neuro-oncology: v1-49.
Doyle, J. and A. M. Khalafallah, et al. (2019). "Association between extent of resection on survival in adult brainstem high-grade glioma patients." Journal of neuro-oncology145(3): 479-486.
Esteve-Codina, A. and F. Alameda, et al. (2020). "RNA-Sequencing and immunohistochemistry reveal ZFN7 as a stronger marker of survival than molecular subtypes in G-CIMP-negative glioblastoma." Clinical cancer research : an official journal of the American Association for Cancer Research.
Fisher, P. G. and S. N. Breiter, et al. (2000). "A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities." Cancer89(7): 1569-76.
Freeman, C. R. and J. P. Farmer (1998). "Pediatric brain stem gliomas: a review." International journal of radiation oncology, biology, physics40(2): 265-71.
Fuchs, I. and W. Kreil, et al. (2002). "Gamma Knife radiosurgery of brainstem gliomas." Acta neurochirurgica. Supplement84: 85-90.
Grimes, D. A. (2008). "The nomogram epidemic: resurgence of a medical relic." Annals of internal medicine149(4): 273-5.
Guillamo, J. S. and A. Monjour, et al. (2001). "Brainstem gliomas in adults: prognostic factors and classification." Brain : a journal of neurology124: 2528-39.
Hargrave, D. and U. Bartels, et al. (2006). "Diffuse brainstem glioma in children: critical review of clinical trials." The Lancet. Oncology7(3): 241-8.
Hargrave, D. and U. Bartels, et al. (2006). "Diffuse brainstem glioma in children: critical review of clinical trials." The Lancet. Oncology7(3): 241-8.
Jallo, G. I. and A. Biser-Rohrbaugh, et al. (2004). "Brainstem gliomas." Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery20(3): 143-53.
Jiang, L. and T. Lin, et al. (2020). "A novel nomogram to predict the overall survival in esthesinoeroblastoma." BMC cancer20(1): 993.
Jovanović, N. and T. Mitrović, et al. (2019). "MGMTThe Impact of Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma." Medicina (Kaunas, Lithuania)55(2).
Khalid, S. I. and R. Kelly, et al. (2019). "Pediatric Brainstem Gliomas: A Retrospective Study of 180 Patients from the SEER Database." Pediatric neurosurgery54(3): 151-164.
Lesniak, M. S. and J. M. Klem, et al. (2003). "Surgical outcome following resection of contrast-enhanced pediatric brainstem gliomas." Pediatric neurosurgery39(6): 314-22.
Li, H. and Y. He, et al. (2020). "The Nomogram Model Predicting Overall Survival and Guiding Clinical Decision in Patients With Glioblastoma Based on the SEER Database." Frontiers in oncology10: 1051.
Louis, D. N. and A. Perry, et al. (2016). "The 2016 World Health Organization classification of tumors of the central nervous system: a summary." Acta neuropathologica131(6): 803-820.
Marcus, K. J. and S. C. Dutton, et al. (2003). "A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma." International journal of radiation oncology, biology, physics55(5): 1182-5.
Maxwell, R. and A. S. Luksik, et al. (2018). "Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma." World neurosurgery119: e1006-e1015.
Moharamzad, Y. and M. Sanei Taheri, et al. (2018). "Brainstem glioma: Prediction of histopathologic grade based on conventional MR imaging." The neuroradiology journal31(1): 10-17.
Mukherjee, D. and V. Antar, et al. (2020). "High-resolution diffusion tensor magnetic resonance imaging of the brainstem safe entry zones." Neurosurgical review43(1): 153-167.
Ostrom, Q. T. and H. Gittleman, et al. (2018). "CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015." Neuro-oncology20(suppl_4): iv1-iv86.
Pincus, D. W. and E. O. Richter, et al. (2006). "Brainstem stereotactic biopsy sampling in children." Journal of neurosurgery104: 108-14.
Qian, X. and H. Jia, et al. (2020). "Risk factors and prediction of second primary cancer in primary female non-metastatic breast cancer survivors." Aging12(19): 19628-19640.
Rengachary, S. and R. A. Rauf (2012). Principles of neurological surgery 3rd edition, Saunders.
Reyes-Botero, G. and K. Mokhtari, et al. (2012). "Adult brainstem gliomas." The oncologist17(3): 388-97.
Sanghavi, S. N. and M. N. Needle, et al. (2003). "A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952." Neuro-oncology5(1): 8-13.
Schwartzentruber, J. and A. Korshunov, et al. (2012). "Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma." Nature482(7384): 226-31.
Scott, R. M. (2004). "Surgical outcome following resection of contrast-enhanced pediatric brainstem gliomas." Pediatric neurosurgery40(2): 99; author reply 100.
Stark, A. M. and M. J. Fritsch, et al. (2005). "Management of tectal glioma in childhood." Pediatric neurology33(1): 33-8.
Sun, T. and W. Wan, et al. (2013). "Clinical outcomes and natural history of pediatric brainstem tumors: with 33 cases follow-ups." Neurosurgical review36(2): 311-9; discussion 319-20.
Sun, T. and Y. Xu, et al. (2020). "Surgical treatment and prognosis of focal brainstem gliomas in children: A 7 year single center experience." Medicine99(36): e22029.
Theeler, B. J. and B. Ellezam, et al. (2015). "Adult brainstem gliomas: Correlation of clinical and molecular features." Journal of the neurological sciences353: 92-7.
Wang, Y. and J. Li, et al. (2013). "Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy." Journal of clinical oncology : official journal of the American Society of Clinical Oncology31(9): 1188-95.
Wong, J. F. and E. J. Brown, et al. (2019). "Fostering open collaboration in drug development for paediatric brain tumours." Biochemical Society transactions47(5): 1471-1479.
Yang, Z. and Y. Bai, et al. (2020). "Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study." Cancer medicine.
Zhu, J. and X. Zhu, et al. (2016). "Parity and thyroid cancer risk: a meta-analysis of epidemiological studies." Cancer medicine5(4): 739-52.